Nuvaxovid
COVID-19 Vaccine (recombinant, adjuvanted)
COVID-19 virus infection
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
Bimervax
COVID-19 Vaccine (recombinant, adjuvanted)
selvacovatein
COVID-19 virus infection
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanAuthorised
VidPrevtyn Beta
COVID-19 Vaccine (recombinant, adjuvanted)
COVID-19 virus infection
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanWithdrawn
EMEA-003191-PIP01-22 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseasesVaccines
PIP number: P/0465/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Emulsion for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002941-PIP01-20-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0250/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002915-PIP01-20-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0046/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution and emulsion for emulsion for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman